A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers
一项随机、双盲、1期、单剂量和多剂量安慰剂对照研究，旨在评估吸入式抗体疗法IN-006在健康志愿者中治疗COVID-19的安全性和药代动力学。
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2025.105582
Moench, Thomas R; Botta, Lakshmi; Farrer, Brian; Lickliter, Jason D; Kang, Hyunah; Park, Yoona; Kim, Cheolmin; Hoke, Marshall; Brennan, Miles; McSweeney, Morgan D; Richardson, Zachary; Whelan, John B; Cho, Jong Moon; Lee, Soo Young; Faurot, Frances; Hutchins, Jeff; Lai, Samuel K
